Yinyi Biotech

Liaoning Biomedical Materials R&D Center Co., Ltd. (referred to as "Yinyi Biotech") was established in October 2004 and listed on the "New Third Board" in December 2015 (Stock Code: 835066). The company specializes in the research, production, and sales of Class III interventional medical devices such as cardiovascular stents. It is a national high-tech enterprise and a pilot innovative enterprise designated by the state. Yinyi Biotech has developed Polymer-free micro-blind hole drug-eluting cardiac stents and drug-coated balloons, which hold authorized Chinese invention patents, filling domestic gaps. The company is a technological leader in China’s new generation of drug-eluting stents and coronary drug-coated balloons. Yinyi Biotech is located in Jinpu New Area. The company has more than 260 employees, with over 95% holding an associate degree or higher. The company owns two GMP-certified clean production workshops and has passed ISO9001 and ISO13485 international quality management system certifications. Yinyi Biotech has led and undertaken more than 30 national, provincial, and municipal scientific and technological projects, including the National "Tenth Five-Year Plan" Science and Technology Key Project, the National "Eleventh Five-Year Plan" Science and Technology Support Program, the National "Twelfth Five-Year Plan" Science and Technology Support Program, and the 863 Program. It is one of the most innovative companies in China’s interventional device field. Yinyi Biotech has built the National-Local Joint Engineering Research Center for Biomedical Materials R&D, the Liaoning Postdoctoral Innovation Practice Base, the Liaoning Enterprise Technology Center, and the Dalian Biomedical Materials Engineering Research Center. It is among the first batch of innovative small and medium-sized enterprises in Liaoning Province, one of the first leading technology enterprises in Dalian City, a high-growth innovative enterprise in Dalian City, and an AAA-level honest taxpayer enterprise in Dalian City. The company was awarded titles such as the Top 100 Innovative Brands Value on China's New Third Board in 2016, the Top 100 Most Innovative Enterprises on China's New Third Board in 2016, the Top 100 Listed Companies in Liaoning Province by Total Assets in 2016, and the Top 100 Companies by Market Value in Liaoning Province in 2017. Over the past five years, the company has paid more than 20 million yuan in taxes annually to the country. Yinyi Biotech has independently developed and launched several innovative products, including third-generation carrier-free drug-eluting stents, PTCA balloon dilatation catheters, metal stents, angiography catheters, and drug-coated balloons. The company has opened sales offices in Beijing, Shanghai, Guangzhou, Xi’an, and Shenyang, cooperating with multiple first-tier agents across China. Its products are sold in more than 30 provinces and regions across China.